Bora Biologics Achieves 2,000L Scale-Up Milestone in US
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
San Diego, California, USA, April 6, 2026 Commercial-Scale Manufacturing Readiness Demonstrated In a significant advancement for biologics manufacturing and...
INCHEON, South Korea & ROCKVILLE, Maryland, USA — March 31, 2026 Samsung Biologics has officially completed the acquisition of...
RANCHO CORDOVA, California, USA | March 24, 2026 In a significant move to advance sustainable pharmaceutical manufacturing, SK pharmteco...
RANCHO CORDOVA, CA, March 17, 2026 SK pharmteco has announced the successful completion of a U.S. Food and Drug...
CHASKA, Minn., December 17, 2025 — Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization (CDMO), has...
Tacares de Grecia, Alajuela, Costa Rica – December 9, 2025 – Forj Medical, the newly formed CDMO created by...
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
Laupheim and Martinsried, Germany, December 2, 2025 — Rentschler Biopharma, a global contract development and manufacturing organization, and Coriolis...
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
Eindhoven, Netherlands, November 3, 2025 — Medical-device CDMO VIVOLTA has signed a long-term agreement for a dedicated production facility...
